Correlation of NLRP3 With Cognitive Dysfunction Early After Heart Valve Replacement Surgery

计划入组 75 人 · 首次发布于 2019 年 12 月 10 日

Expression of Inflammasomes in HCV Patients

计划入组 50 人 · 首次发布于 2020 年 1 月 28 日

Role of Inflammasomes in COVID-19 Disease

计划入组 99 人 · 首次发布于 2020 年 5 月 12 日

NLRP3 inflammasome inhibitor(Enveda)

NLRP3 inflammasome inhibitor (cardiac inflammation)

NLRP3 inflammasome inhibitor (unidentified indication)

ZyVersa Highlights Data on Inflammasome Inhibition for Type 2 Diabetes Prevention

Inflammasome Therapeutics' K8 Implant Reduces Geographic Atrophy Lesion Growth by 53% in Phase I Trial

ZyVersa's IC 100 Shows Promise as Disease-Modifying Treatment for Parkinson's Disease